UPS is investing $2 billion through 2028 to expand its international, healthcare, and supply chain solutions businesses, the company announced. The deployments build on investments that began in 2024 and continue across the three units over the next two years.
Healthcare logistics and international operations carry premium pricing and longer contract terms than ground shipping, reducing exposure to spot-rate competition. Traditional parcel volumes face pressure from e-commerce saturation and economic uncertainty.
UPS has expanded its healthcare footprint significantly since 2020, when it acquired Marken, a clinical trial logistics specialist, for an undisclosed sum. The company now operates temperature-controlled distribution networks and specialized handling for pharmaceuticals, medical devices, and biologics. Healthcare represented one of the company's fastest-growing segments in 2025, though UPS has not disclosed its share of total revenue.
The international and supply chain solutions units address separate demand vectors. International operations cover cross-border parcel, freight, and forwarding services, where UPS competes with FedEx, DHL, and regional carriers. Supply chain solutions encompasses consulting, warehousing, customs brokerage, and visibility software sold to enterprise shippers seeking to optimize end-to-end logistics operations rather than optimize single legs of transport.
UPS did not disclose how the $2 billion breaks down across the three units or provide incremental margin expectations. The company has faced margin compression in parcel operations as labor costs rise and competitive pricing tightens. UPS is prioritizing higher-value service lines in response.
The timeframe aligns with UPS's labor agreement negotiated in 2023, which front-loaded wage increases and reduced opportunity for headcount optimization. The company has responded by automating sorting facilities and pivoting capacity toward services with steeper pricing.
UPS has invested over $4 billion in capital expenditure annually in recent years, with healthcare and international logistics accounting for a growing share. The $2 billion commitment through 2028 represents a targeted allocation rather than a fresh total. Investors will watch whether the company discloses segment-level profitability for healthcare and supply chain solutions in coming quarters, a metric that does not currently appear in earnings breakouts.
